Novartis
KYMRIAH
Manufacturer:
Novartis
Name:
KYMRIAH
Category:
Q Code
HCPCS:
Q2042
NDC(s):
00078-0846-19, 00078-0958-19,
Primary Type:
Cancer
Route of Administration:
Intravenous
About:
KYMRIAH is a Cancer drug manufactured by Novartis and administered via the Intravenous route of administration. The Q Code: Q2042 is aligned to the drug KYMRIAH.